Table 2 Adverse events with everolimus plus fulvestrant.
Adverse events | All grades | Grade 3 and 4 | ||
|---|---|---|---|---|
Number of patients N = 57 | % | Number of patients N = 57 | % | |
Hyperglycemia | 13 | 22.8 | 0 | 0 |
Mucositis | 39 | 68.4 | 6 | 10.5 |
Pneumonitis | 9 | 15.8 | 1 | 1.8 |
Decreased weight | 18 | 31.6 | 1 | 1.8 |
Nausea | 8 | 14.0 | 0 | 0 |
Rash | 18 | 31.6 | 0 | 0 |
Diarrhea | 13 | 22.8 | 0 | 0 |
Constipation | 6 | 10.5 | 0 | 0 |
hypercholesterolemia | 16 | 28.1 | 0 | 0 |
Neutropenia | 4 | 7.0 | 1 | 1.8 |
Hypertriglyceridemia | 15 | 26.3 | 2 | 3.5 |
Alanine aminotransferase increased | 15 | 26.3 | 0 | 0 |
Asthenia | 27 | 47.4 | 0 | 0 |
Dyspnea | 15 | 26.3 | 0 | 0 |
